Breaks Categories: News

ThursdayDec 10, 2020 10:09 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Lays Groundwork for Move into World of Psychedelics

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, today announced its engagement of a globally recognized operations, compliance and regulatory consulting firm to advise on the company’s application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (“CDSA”). “Having the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries assures that we will submit a fully-compliant Dealers Licence application to Health Canada in the shortest time possible,” said Pure Extracts…

Continue Reading

WednesdayDec 09, 2020 10:03 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces LOI with Owner of PURICA(TM) Brand of Wellness Product

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, recently signed a letter of intent with the Nutraceutical Medicine Company Inc. (“PURICA”). PURICA owns and distributes the PURICA product line of full-spectrum, mushroom-derived wellness products. Pure Extracts anticipates the PURICA brand will support PULL’s expansion into the functional mushroom sector. For the past two decades, PURICA has offered natural and whole food products that are backed by science. The company’s Immune 7 formulation has been the Alive Award gold winner for the best immunity product in Canada two years in a…

Continue Reading

WednesdayDec 02, 2020 10:22 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Working Collaboration with Leading Pharmaceutical Science Inventor

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has announced its partnership with Dr. Alexander MacGregor, a key scientific advisor the company. A renowned expert in pharmaceutical technology and novel drug-delivery systems, MacGregor is a dean of faculty and a distinguished professor of biopharmaceutics and current president of the Toronto Institute of Pharmaceutical Technology (“TIPT “), the premier post-graduate institute of pharmaceutical sciences, technology and research in North America. He is also the CEO of TIPT’s parent company, Transpharm Canada Inc., which conducts cannabis testing and clinical trials. MacGregor will be working with…

Continue Reading

MondayNov 30, 2020 10:08 am

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Advances Move into Field of Mushroom Extractions

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sectors, on Thursday provided an update and overview regarding its expansion into the functional mushroom wellness sector. According to the update, interest is climbing sharply in functional and medicinal mushrooms, particularly regarding medicinal opportunities. Pure Extracts noted increased institutional interest in the field of psychedelics in general and with a focus on promising mushroom varieties such as psilocybin specifically. As a result of the encouraging and growing interest in the sector, Pure Extracts has commenced the expansion of its…

Continue Reading

WednesdayNov 25, 2020 11:35 am

PsychedelicNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Announces Executive Leadership Changes

Champignon Brands (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) has announced that its executive leadership team will be changing; these changes follow last month’s naming of a new CEO and board chair along with a new vice chair. As a result of this week’s changes, the company is actively looking for new key executives, including a chief financial officer, chief general counsel and senior vice president of investor and public communications. The company also plans to announce additional board members coming from key business and science segments. Current board members who are remaining include Dr. Roger McIntyre, chair and CEO; Bill Wilkerson, vice…

Continue Reading

ThursdayNov 19, 2020 1:24 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) CEO Provides Corporate Update

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company specializing in cannabis, hemp and mushroom products, has released a corporate update from CEO and director Ben Nikolaevsky. The update includes information about the company’s new state-of-the-art facility, located in Pemberton, British Columbia, about 20 minutes north of Whistler, which was built to European Union GMP standards. The update also provides an overview of the company’s plans to undertake the operations of toll processing and white labelling for LPs that lack the extraction expertise and expensive equipment to provide their own materials. In addition, Pure Extracts is developing its own private…

Continue Reading

FridayNov 13, 2020 1:33 pm

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) CEO Talks Company’s Psychedelic Research, Plans on Live Trading Show

Cybin (NEO: CYBN) CEO Doug Drysdale was featured on a recent episode of TraderTV Live. Broadcast live from the DTTW trading floor, TraderTV Live is the first and only professional trading show on YouTube Live. During the show, Drysdale discussed Cybin’s work on psychedelic medical research, including the company’s current phase 2 study. He also provided an overview of Cybin’s strategic plan moving forward in the development process. In addition, Drysdale talked about the company recent listing move to the NEO exchange and plans for an uplisting to a U.S. exchange in the future. “We recently closed our series B…

Continue Reading

ThursdayNov 12, 2020 3:06 pm

PsychedelicNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Announces Board Appointment of Dwight Duncan

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp, and functional mushroom sectors, on Tuesday announced the appointment of Dwight Duncan to its board of directors. Duncan serves as a senior strategic advisor at McMillan LLP, a large Canadian full-service business law firm. He also serves as a principal of McMillan Vantage, McMillan LLP’s wholly owned public policy advisory firm, and chairs the board of directors of the Windsor Detroit Bridge Authority, the federal crown corporation overseeing the construction and operation of the $5.7 billion Gordie Howe International Bridge. “We are pleased to welcome Dwight Duncan…

Continue Reading

ThursdayNov 12, 2020 12:43 pm

PsychedelicNewsBreaks – Rritual Receives USDA Organic Certification, Official Confirmation of Product Quality

Rritual announced that it has received the United States Department of Agriculture (“USDA”) Organic Certification. Awarded only after a demanding vetting process, the seal confirms the high quality of Rritual’s product lineup and manufacturing process. Rritual launched its original product lineup in September, which features products formulated with mindfully selected functional mushrooms and adaptogenic herbs. The products are designed to help relieve stress, improve cognitive function and support the immune system. As a Certified Organic company, Rritual meets a strict process that verifies its ingredients are free from antibiotics, toxic pesticides, synthetic hormones and genetically modified organisms (“GMOs”). In addition, Rritual…

Continue Reading

WednesdayNov 11, 2020 10:21 am

PsychedelicNewsBreaks – Cybin Inc. (NEO: CYBN) Goes Public on Canada’s Next-Gen Stock Exchange

Cybin (NEO: CYBN), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, today made its debut on the global public markets and is now trading on the NEO Exchange under the symbol “CYBN.” The company, which focuses on psychedelic drug development, unique delivery mechanisms, improved novel compounds and protocols, recently closed a C$45 million subscription receipt financing in relation to its reverse takeover transaction. This signified the largest subscription receipt financing in the Canadian psychedelic sector. “Today marks a meaningful milestone for our company, as our shares begin trading on the NEO Exchange under the ticker…

Continue Reading